Label | TTM Value / Value | Unit | Change % |
---|---|---|---|
Current Ratio | 638 | % | -43.1% |
Return On Assets | -124 | % | -46.3% |
Label | TTM Value / Value | Unit | Change % |
---|---|---|---|
Entity Common Stock, Shares Outstanding | 33.2M | shares | +10% |
Common Stock, Shares, Outstanding | 30.2M | shares | +0.25% |
Entity Public Float | 89M | USD | +22% |
Common Stock, Value, Issued | 30.2K | USD | +0.25% |
Weighted Average Number of Shares Outstanding, Basic | 30.2M | shares | +0.21% |
Weighted Average Number of Shares Outstanding, Diluted | 30.2M | shares | +0.21% |
Label | TTM Value / Value | Unit | Change % |
---|---|---|---|
Research and Development Expense | 46.2M | USD | -15.7% |
General and Administrative Expense | 37.7M | USD | -22.9% |
Operating Income (Loss) | -83.9M | USD | +19.1% |
Nonoperating Income (Expense) | 3.91M | USD | -20.3% |
Net Income (Loss) Attributable to Parent | -80M | USD | +19% |
Earnings Per Share, Basic | -2.65 | USD/shares | +19.2% |
Earnings Per Share, Diluted | -2.65 | USD/shares | +19.2% |
Label | TTM Value / Value | Unit | Change % |
---|---|---|---|
Cash and Cash Equivalents, at Carrying Value | 3.86M | USD | -5.73% |
Assets, Current | 45.8M | USD | -53% |
Other Assets, Noncurrent | 22K | USD | -49% |
Assets | 45.8M | USD | -53% |
Accounts Payable, Current | 4.13M | USD | +17.8% |
Accrued Liabilities, Current | 6.16M | USD | -29.1% |
Liabilities, Current | 10.3M | USD | -15.6% |
Liabilities | 10.3M | USD | -15.6% |
Retained Earnings (Accumulated Deficit) | -641M | USD | -14.3% |
Stockholders' Equity Attributable to Parent | 35.5M | USD | -58.4% |
Liabilities and Equity | 45.8M | USD | -53% |
Label | TTM Value / Value | Unit | Change % |
---|---|---|---|
Net Cash Provided by (Used in) Operating Activities | -13M | USD | +21% |
Net Cash Provided by (Used in) Financing Activities | 222K | USD | |
Net Cash Provided by (Used in) Investing Activities | 10.1M | USD | -74.9% |
Common Stock, Shares Authorized | 150M | shares | 0% |
Common Stock, Shares, Issued | 30.2M | shares | +0.25% |
Common Stock, Par or Stated Value Per Share | 0 | USD/shares | 0% |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | 23.5M | USD | +4686% |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | 3.86M | USD | -5.73% |
Deferred Tax Assets, Valuation Allowance | 115M | USD | +4.74% |
Preferred Stock, Shares Authorized | 200M | shares | 0% |
Additional Paid in Capital | 676M | USD | +4.67% |
Share-based Payment Arrangement, Expense | 8.3M | USD | -26.9% |
Preferred Stock, Par or Stated Value Per Share | 0 | USD/shares | 0% |